Sign In
Buy HEPA
$0.0600
-0.0030 (-4.76%)
At Close: Jun 03, 2026
Enanta Pharmaceuticals Announces the Appointment of Mark G. Foletta to Its Board of Directors | | IT Business Net
12:02pm, Monday, 29'th Jun 2020
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases
Wall Street : Les valeurs à suivre à Wall Street
12:01pm, Monday, 29'th Jun 2020
PARIS (Reuters) - Principales valeurs à suivre lundi à Wall Street, où les contrats à terme sur indices suggèrent une ouverture en hausse de 0,5% environ …
USA-Les valeurs à suivre à Wall Street (actualisé)
11:55am, Monday, 29'th Jun 2020
(Actualisé avec Facebook, Twitter et Snap, annonce de Coty,
Intercept Pharmaceuticals, Gilead, cours en avant-Bourse)
PARIS, 29 juin (Reuters) - Principales valeurs à suivre
lundi à Wall Street
Intercept Pharmaceuticals receives FDA Complete Response Letter for treatment for fibrosis due to NASH
11:24am, Monday, 29'th Jun 2020
Intercept Pharmaceuticals Inc. shares undefined tumbled more than 30% in premarket trade Monday, after the company said it has received a U.S. Food and Drug...
Legend Biotech (NASDAQ:PLRX) Reaches New 12-Month High at $32.79
11:10am, Monday, 29'th Jun 2020
Shares of Legend Biotech Corporation (NASDAQ:PLRX) hit a new 52-week high on Monday . The company traded as high as $32.79 and last traded at $32.75, with a volume of 445 shares trading hands. The sto
Cowen Initiates Coverage on Legend Biotech (NASDAQ:PLRX)
08:26am, Monday, 29'th Jun 2020
Stock analysts at Cowen began coverage on shares of Legend Biotech (NASDAQ:PLRX) in a research report issued to clients and investors on Monday, BenzingaRatingsTable reports. The brokerage set an “o
Integrating Echosens’ FibroScan into MetaPhy’s Chronic Care Liver Disease Management Program Impacts Patient Outcomes, Costs, Financial Performance
Financial Comparison: GENFIT S A/ADR (GNFT) versus The Competition
02:20am, Sunday, 28'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare GENFIT S A/AD
GENFIT S A/ADR (GNFT) versus Its Rivals Head to Head Contrast
01:16am, Friday, 26'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare GENFIT S A/AD
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
Poxel : annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 24 juin 2020 | Zone bourse
03:02pm, Thursday, 25'th Jun 2020What Algernon is doing to potentially combat COVID-19
01:00pm, Thursday, 25'th Jun 2020
Algernon Pharmaceuticals Inc. (CSE: AGN | OTCQB: AGNPF | FSE: AGW) is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney di…
Poxel annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 24 juin 2020
12:00am, Thursday, 25'th Jun 2020
Regulatory News : POXEL SA (Paris:POXEL) (Euronext : POXEL - FR0012432516), société biopharmaceutique spécialisée dans le développement de traitements
Combination Pill From Myovant Reduces Pain From Endometriosis, Trial Shows
01:32pm, Wednesday, 24'th Jun 2020
Read about the biggest pharmaceutical development and pricing stories from the past week in KHN’s Prescription Drug Watch roundup.
Advocates Want More Warnings From FDA On Diabetes Drug Linked To Fatal Reactions
01:32pm, Wednesday, 24'th Jun 2020
Because the drug can cause a potentially fatal condition called ketoacidosis in diabetic patients, advocates are calling on the FDA to issue a “black box” warning–the most severe …
